CORAR Leadership
CORAR Executive Director
Michael J. Guastella, MS, MBA - Executive Director
Before joining CORAR in 2011, Michael held various sales and marketing leadership roles in the imaging, biotechnology, clinical laboratory, and radiopharmaceutical industries and was most recently the Vice President of Marketing and Product Development for Cardinal Health Nuclear Pharmacy Services. Michael has served on the CORAR Board of Directors for 10 years and has held other industry leadership positions including Co-Chairman of the CORAR Healthcare Policy Committee – Reimbursement. Michael received his B.S. and M.S. degrees from UCLA and earned his MBA from the UCLA Anderson School of Management.
2026 CORAR Corporate Officers
Chairman
David Pellicciarini - Vice President Industry Affairs and Corporate Radiation Safety Officer, Cardinal Health Nuclear & Precision Health Solutions
Vice Chairman
Shahe Bagerdjian - President, International Isotopes, Inc.
Secretary/Treasurer
James T. Harvey - Senior Vice President & Chief Science Officer, NorthStar Medical Radioisotopes, LLC
2026 CORAR Board Members
Shahe Bagerdjian (International Isotopes, Inc.)
Roy W. Brown (Curium)
Scott Claunch (TerraPower Isotopes)
Roger Estafanos (ITM USA, Inc.)
Paul Gauthier (Eckert & Ziegler Radiopharma, Inc.)
Shaemus Gleason (Clarity Pharmaceuticals)
Michael Gwinner (Novartis Pharmaceuticals Corporation)
James T. Harvey PhD (NorthStar Medical Technologies, LLC)
Amos Hedt (Persepctive Therapeutics, Inc.)
Ben Hickey (RayzeBio, a Bristol Myers Squibb Company)
Rohan Jain (Nusano, Inc)
Michelle Mathy (Lantheus)
Campbelle Mongilia (SUN Radiopharma)
Michael Pintek (Cardinal Health Nuclear & Precision Health Solutions)
Eric Schutt (SHINE Technologies LLC)
Dominic Siewko (Nucleus RadioPharma)
Patrick Smith (University of Missouri Research Reactor (MURR))
Jason Van Wart (BWXT Medical)
Chris Wagner (Eden Radioisotopes, LLC)
Jim Wilson (Eckert & Ziegler Isotope Products, Inc.)